Literature DB >> 10519048

Sequence of neurodegeneration and accumulation of phosphorylated tau in cultured neurons after okadaic acid treatment.

D Kim1, J Su, C W Cotman.   

Abstract

Within neurofibrillary tangles and dystrophic neurites of Alzheimer's disease (AD), the cytoskeletal protein tau is abnormally hyperphosphorylated. In the present study, we examined the effect of okadaic acid (OA), a protein phosphatase inhibitor, in rat cultured neurons. Low concentrations of OA induce degeneration of neurites, rounding of cell bodies, detachment from the substratum, and eventual neuronal death. During OA-induced degeneration, SMI-31 immunoreactivity became punctate in neurites at 6 h after OA treatment, and over time, accumulated in cell bodies and dystrophic neurites. Hyperphosphorylation of tau and marked loss of MAP-2-positive dendrites occurred after 6 h of treatment with OA. Thereafter, AT-8 and PHF-1 immunoreactivity accumulated in cell bodies and subsequently appeared in distal axon-like neurites. These results demonstrate that OA treatment induced hyperphosphorylation of tau and preferential dendritic damage, with subsequent accumulation of phosphorylated tau in cell bodies and dystrophic axon-like neurites. OA-induced neurodegeneration may provide a useful model to study AD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10519048     DOI: 10.1016/s0006-8993(99)01724-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits.

Authors:  Dave J Koss; Lianne Robinson; Anna Mietelska-Porowska; Anna Gasiorowska; Kristina Sepčić; Tom Turk; Marcel Jaspars; Grazyna Niewiadomska; Roderick H Scott; Bettina Platt; Gernot Riedel
Journal:  Cell Mol Life Sci       Date:  2015-06-13       Impact factor: 9.261

Review 2.  Molecular and cellular mechanism of okadaic acid (OKA)-induced neurotoxicity: a novel tool for Alzheimer's disease therapeutic application.

Authors:  Pradip K Kamat; Shivika Rai; Supriya Swarnkar; Rakesh Shukla; Chandishwar Nath
Journal:  Mol Neurobiol       Date:  2014-04-08       Impact factor: 5.590

3.  Protein phosphatase 2A restrains DLK signaling to promote proper Drosophila synaptic development and mammalian cortical neuron survival.

Authors:  Margaret Hayne; Aaron DiAntonio
Journal:  Neurobiol Dis       Date:  2021-12-16       Impact factor: 7.046

4.  Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia.

Authors:  Emmanuel Planel; Alexis Bretteville; Li Liu; Laszlo Virag; Angela L Du; Wai Haung Yu; Dennis W Dickson; Robert A Whittington; Karen E Duff
Journal:  FASEB J       Date:  2009-03-11       Impact factor: 5.191

5.  Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo.

Authors:  Emmanuel Planel; Pavan Krishnamurthy; Tomohiro Miyasaka; Li Liu; Mathieu Herman; Asok Kumar; Alexis Bretteville; Helen Y Figueroa; Wai Haung Yu; Robert A Whittington; Peter Davies; Akihiko Takashima; Ralph A Nixon; Karen E Duff
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

6.  Tau phosphorylation and cleavage in ethanol-induced neurodegeneration in the developing mouse brain.

Authors:  Mariko Saito; Goutam Chakraborty; Rui-Fen Mao; Sun-Mee Paik; Csaba Vadasz; Mitsuo Saito
Journal:  Neurochem Res       Date:  2010-01-05       Impact factor: 3.996

7.  Identification of differentially expressed genes in SHSY5Y cells exposed to okadaic acid by suppression subtractive hybridization.

Authors:  Vanessa Valdiglesias; Juan Fernández-Tajes; Eduardo Pásaro; Josefina Méndez; Blanca Laffon
Journal:  BMC Genomics       Date:  2012-01-27       Impact factor: 3.969

8.  Comparison of neurons derived from mouse P19, rat PC12 and human SH-SY5Y cells in the assessment of chemical- and toxin-induced neurotoxicity.

Authors:  Dina Popova; Jessica Karlsson; Stig O P Jacobsson
Journal:  BMC Pharmacol Toxicol       Date:  2017-06-05       Impact factor: 2.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.